Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-α and -γ

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 2 51-2, 2005, Pages

  Nie, Wenxian ^a   Sweetser, Seth ^a   Rinella, Mary ^a   Green, Richard M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Gene expression

Indexed keywords

CARRIER PROTEIN; LUCIFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SLC22A1; TETRYLAMMONIUM BROMIDE; UNCLASSIFIED DRUG;

ARTICLE; BODY WEIGHT; CATION TRANSPORT; CELL CULTURE; CLONING; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; GENETIC TRANSFECTION; LIPID METABOLISM; LIVER FUNCTION; LIVER SIZE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; CATECHOLAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; CATION TRANSPORT PROTEINS; CELL LINE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED STRAINS; PEROXISOME PROLIFERATORS; PPAR ALPHA; PPAR GAMMA; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 12344327392     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00057.2004     Document Type: Article

References (24)

1. Coates G, Nissim I, Battarbee H, and Welbourne T. Glitazones regulate glutamine metabolism by inducing a cellular acidosis in MDCK cells. Am J Physiol Endocrinol Metab 283: E729-E737, 2002.
2. Desai SH, Boskovic G, Eastham L, Dawson M, and Niles RM. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells. Biochem Pharmacol 59: 1265-1275, 2000.
3. Eibl G, Wente MN, Reber HA, and Hines OJ. Peroxisome proliferator- activated receptor gamma induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun 287: 522-529, 2001.
4. Green RM, Gollan JL, Hagenbuch B, Meier PJ, and Beier DR. Regulation of hepatocyte bile salt transporters during hepatic regeneration. Am J Physiol Gastrointest Liver Physiol 273: G621-G627, 1997.
5. Green RM, Lo K, Sterritt C, and Beier DR. Cloning and functional expression of a mouse liver organic cation transporter. Hepatology 29: 1556-1562, 1999.
6. Hallenbeck PL, Minucci S, Lippoldt R, Phyillaier M, Horn V, Ozato K, and Nikodem VM. Differential 9-cis-retinoic acid-dependent transcriptional activation by murine retinoid X receptor alpha (RXR alpha) and RXR beta. Role of cell type and RXR domains. J Biol Chem 271: 10503-10507, 1996.
7. Hsueh WA and Law R. The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease. Am J Cardiol 92: 3J-9J, 2003.
8. Jemnitz K, Veres Z, Monostory K, and Vereczkey L. Glucuronidation of thyroxine in primary monolayer cultures of rat hepatocytes: in vitro induction of udp-glucuronosyltranferases by methylcholanthrene, clofibrate, and dexamethasone alone and in combination. Drug Metab Dispos 28: 34-37, 2000.
9. Jonker JW, Wagenaar E, Mol CA, Buitelaar M, Koepsell H, Smit JW, and Schinkel AH. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene. Mol Cell Biol 21: 5471-5477, 2001.
10. Kim EJ, Kwon KJ, Park JY, Lee SH, Moon CH, and Baik EJ. Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2. Brain Res 941: 1-10, 2002.
11. Koepsell H. Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 60: 243-266, 1998.
12. Koepsell H, Schmitt BM, and Gorboulev V. Organic cation transporters. Rev Physiol Biochem Pharmacol 150: 36-90, 2003.
13. Kok T, Bloks VW, Wolters H, Havinga R, Jansen PL, Staels B, and Kuipers F. Peroxisome proliferator-activated receptor alpha (PPARα)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 369: 539-547, 2003.
14. Kok T, Wolters H, Bloks VW, Havinga R, Jansen PL, Staels B, and Kuipers F. Induction of hepatic ABC transporter expression is part of the PPARα-mediated fasting response in the mouse. Gastroenterology 124: 160-171, 2003.
15. Lake BG, Gray TJ, Stubberfield CR, Beamand JA, and Gangolli SD. Induction of lauric acid hydroxylation and maintenance of cytochrome P-450 content by clofibrate in primary cultures of rat hepatocytes. Life Sci 33: 249-254, 1983.
16. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, Caporale R, Laffi G, Pinzani M, and Gentilini P. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 119: 466-478, 2000.
17. Martin G, Poirier H, Hennuyer N, Crombie D, Fruchart JC, Heyman RA, Besnard P, and Auwerx J. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective retinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. J Biol Chem 275: 12612-12618, 2000.
18. Motojima K, Passilly P, Peters JM, Gonzalez FJ, and Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 273: 16710-16714, 1998.
19. Neve BP, Fruchart JC, and Staels B. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol 60: 1245-1250, 2000.
20. Noga AA and Vance DE. Insights into the requirement of phosphatidylcholine synthesis for liver function in mice. J Lipid Res 44: 1998-2005, 2003.
21. Pavlova A, Sakurai H, Leclercq B, Beier DR, Yu AS, and Nigam SK. Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am J Physiol Renal Physiol 278: F635-F643, 2000.
22. Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, Ferrin TE, Herskowitz I, and Giacomini KM. Pharmacogenetics of membrane transporters investigators. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 13: 5902-5907, 2003.
23. Sinclair CJ, Chi KD, Subramanian V, Ward KL, and Green RM. Functional expression of a high affinity mammalian hepatic choline/organic cation transporter. J Lipid Res 41: 1841-1848, 2000.
24. Van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, and Meijer DK. Drug uptake systems in liver and kidney. Curr Drug Metab 4: 185-211, 2003.